Chronic myringitis

H8_MYRINGCHRON

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H73.1
  • Hospital discharge: ICD-9 3841
  • Cause of death: ICD-10 H73.1
  • Cause of death: ICD-9 3841

2 out of 7 registries used, show all original rules.

176

4. Check minimum number of events

None

176

5. Include endpoints

None

176

6. Filter based on genotype QC (FinnGen only)

169

Control definitions (FinnGen only)

Control exclude
H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H73
Name in latin
Myringitis chronica

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1468 726 734
Only index persons 1375 692 683
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.02
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 43.87 44.67 43.07
Only index persons 44.96 45.66 44.24

-FinnGen-

Key figures

All Female Male
Number of individuals 169 93 76
Unadjusted period prevalence (%) 0.03 0.03 0.03
Median age at first event (years) 57.29 56.16 58.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
176
Matched controls
1760
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H73.1
ICD-10 Finland
Chronic myringitis
+∞
248.4
174
*
UDC00
NOMESCO Finland
Ear microscopy
45.6
150.2
112
65
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
+∞
91.9
80
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
24.0
78.4
64
41
H66.9
ICD-10 Finland
Otitis media, unspecified
20.7
60.5
51
34
DCD00
NOMESCO Finland
Myringoplasty
+∞
51.6
47
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
14.6
49.4
51
48
DFF00
NOMESCO Finland
Pure tone audiometry
9.6
41.2
60
90
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
439.2
36.4
35
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
376.1
31.9
31
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.8
30.3
61
127
S02CA02
ATC
flumetasone and antiinfectives; otic
10.0
28.4
36
44
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
68.9
25.9
29
5
H01
ICPC
Ear pain/earache
6.2
24.0
50
106
WX720
NOMESCO Finland
Own respiration
10.6
23.6
28
31
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
+∞
22.4
21
*
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
+∞
22.4
21
*
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
131.4
22.1
23
*
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
+∞
21.3
20
*
DC1AD
NOMESCO Finland
Temporalbone CT
124.9
21.1
22
*
H60.3
ICD-10 Finland
Other infective otitis externa
22.9
20.3
29
15
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic
28.7
20.2
27
11
H71
ICD-10 Finland
Cholesteatoma of middle ear
+∞
20.2
19
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.8
19.5
57
160
DFF15
NOMESCO Finland
Speech audiometry
8.5
18.8
26
35
H04
ICPC
Ear discharge
16.2
18.6
30
22
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.8
16.6
76
292
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
52.9
16.4
19
*
WX704
NOMESCO Finland
Intubation
6.2
15.0
28
52
H60.8
ICD-10 Finland
Other otitis externa
11.5
14.0
26
26
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.3
13.8
85
386
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
75.5
12.8
14
*
H65.2
ICD-10 Finland
Chronic serous otitis media
139.5
12.6
13
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
139.5
12.6
13
*
TDA90
NOMESCO Finland
Removal wax from ear
20.7
11.8
17
9
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
11.6
11
*
H73.0
ICD-10 Finland
Acute myringitis
+∞
11.6
11
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
11.6
11
*
WX725
NOMESCO Finland
Noninvasive ventilation
5.7
11.1
22
43
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
5.6
10.8
22
44
SPAT1044
SPAT
Tympanometry
15.5
10.7
17
12
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.0
10.6
117
705
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
+∞
10.5
10
*
DCD10
NOMESCO Finland
Tympanoplasty
+∞
10.5
10
*
4122
FHL
Tympanostomy (tympanic tube)
+∞
10.5
10
*
H65.0
ICD-10 Finland
Acute serous otitis media
34.9
10.5
13
*
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
10.3
54
217
DAX08
NOMESCO Finland
Fitting of hearing aid
5.1
9.8
22
48
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
9.6
25
62
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
9.5
9
*
H13
ICPC
Plugged feeling ear
3.0
9.1
49
199
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
11.6
8.5
15
14
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
8.2
8.4
18
24
DCA40
NOMESCO Finland
Fat patching or other similar technique without opening of tympanic membrane
+∞
8.4
8
*
H71
ICPC
Acute otitis media/myringitis
18.3
8.2
12
7
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
18.3
8.2
12
7
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
23.3
8.1
11
5
SPAT1262
SPAT
Handing over of treatment supplies
3.0
7.8
42
169
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
47.1
7.8
9
*
H70
ICPC
Otitis externa
10.7
7.7
14
14
H60
ICD-10 Finland
Otitis externa
4.4
7.6
20
50
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
7.5
39
154
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
83.5
7.5
8
*
H73.8
ICD-10 Finland
Other specified disorders of tympanic membrane
+∞
7.3
7
*
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
+∞
7.3
7
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
10.7
7.2
13
13
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.9
7.1
22
62
J01DA08
ATC
[U] cefaclor
3.3
7.1
29
99
R01AD08
ATC
fluticasone; nasal
2.4
6.9
60
307
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
4.3
6.8
18
45
J01DA09
ATC
[U] cefadroxil
2.5
6.7
56
281
D07AB02
ATC
hydrocortisone butyrate; topical
2.4
6.7
65
349
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
4.2
6.6
18
46
H29
ICPC
Ear symptom/complaint other
3.1
6.3
29
106
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
6.2
6.3
16
28
H72
ICD-10 Finland
Perforation of tympanic membrane
+∞
6.3
6
*
H90.2
ICD-10 Finland
Conductive hearing loss, unspecified
+∞
6.3
6
*
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
+∞
6.3
6
*
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
+∞
6.3
6
*
SPAT1263
SPAT
Sampling
2.2
6.1
86
533
-31
ICPC
Medical examin/health eval partial
3.8
6.1
19
54

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
69
159
6.49
30.98
2.3
1.7
—
—
—
0
0
34
89
4.50
12.33
2.5
3.0
54.90
166.12
ng/l
2.66
29
81
49
190
3.19
9.91
1.7
1.5
—
—
—
0
0
45
204
2.62
6.61
1.8
2.1
—
—
—
0
0
59
316
2.30
5.98
3.5
3.6
1.02
1.02
kg/l
0.81
11
44
49
247
2.36
5.68
2.4
3.4
104.84
99.30
ng/l
0.03
31
186
130
975
2.28
5.46
4.3
4.1
—
—
—
0
0
141
1101
2.41
5.27
4.1
3.9
14.74
14.67
pmol/l
0.13
127
984
22
78
3.08
5.03
3.0
17.2
—
—
—
0
0
140
1117
2.24
4.53
6.1
7.7
72.47
79.68
u/l
1.94
131
1048
171
1556
4.48
4.00
10.2
10.5
26.56
26.46
u/l
0.03
166
1505
110
829
1.87
3.87
3.7
5.7
6.93
6.76
mmol/l
0.24
95
774
67
433
1.88
3.84
3.6
3.8
3.88
10.81
mg/mmol
1.42
37
265
68
444
1.87
3.76
2.9
3.1
7.55
7.52
mmol/l
0.02
60
374
90
655
1.77
3.39
12.7
14.4
1.10
1.27
inr
3.27
19
200
93
686
1.75
3.32
5.3
7.6
1.23
1.21
mmol/l
1.07
80
580
62
409
1.80
3.24
3.3
3.2
2644.09
227.97
mg/l
0.71
34
264
25
123
2.20
2.99
1.2
1.2
—
—
—
0
0
122
989
1.76
2.98
4.0
3.8
—
—
—
0
0
48
305
1.79
2.79
1.7
1.7
135897827.64
470.61
pmol/l
0.49
39
259
116
937
1.70
2.77
3.6
4.2
—
46.07
—
0
14
153
1342
2.07
2.75
5.3
4.6
1.83
1.89
mu/l
0.26
142
1219
19
369
0.46
2.74
2.6
3.8
90.74
90.46
%
0.01
19
359
72
523
1.64
2.54
2.1
2.0
95.58
95.55
pmol/l
0.00
40
268
25
132
2.04
2.51
1.8
2.1
409.04
395.14
nmol/l
0.14
25
121
162
1471
2.27
2.34
11.0
13.9
20.62
22.80
mg/l
0.39
133
1137
128
1091
1.64
2.20
3.6
3.9
9.87
11.57
mm/h
0.95
122
1001
38
248
1.68
1.98
1.5
1.7
995.56
1206.72
nmol/l
1.09
32
194
58
421
1.56
1.98
1.6
2.1
110.38
155.02
u/l
1.80
52
401
61
454
1.53
1.84
2.2
2.9
57.25
66.07
u/l
0.39
53
423
77
603
1.49
1.82
3.7
5.2
36.76
35.73
g/l
0.86
69
568
49
652
0.66
1.72
9.3
9.2
0.00
0.00
e9/l
0.91
42
531
0
49
0.00
1.71
0.0
3.1
—
—
—
0
0
92
754
1.46
1.70
5.5
6.8
9.95
11.47
umol/l
1.76
86
721
44
311
1.55
1.66
1.5
1.5
20.87
22.30
nmol/l
0.27
37
258
16
84
2.00
1.66
2.9
3.6
4.62
4.52
pmol/l
0.25
16
72
27
404
0.61
1.58
2.0
2.8
—
—
—
0
0
0
42
0.00
1.55
0.0
1.1
—
—
—
0
0
12
58
2.15
1.53
1.2
1.1
—
—
—
0
0
14
249
0.52
1.52
1.8
3.1
2.49
2.45
mmol/l
0.48
14
215
154
1419
1.68
1.48
5.3
4.4
6.09
5.95
mmol/l
0.57
142
1311
23
143
1.70
1.44
1.7
1.8
—
—
—
0
0
158
1469
1.74
1.42
5.5
4.9
2.69
2.76
mmol/l
0.41
144
1360
156
1447
1.69
1.39
4.9
4.4
4.55
4.65
mmol/l
0.54
145
1349
147
1347
1.55
1.35
6.3
5.6
40.51
39.95
mmol/mol
0.30
136
1260
29
409
0.65
1.29
2.2
2.9
0.23
0.66
e6/l
1.52
23
297
68
549
1.39
1.28
2.7
3.7
16.23
34.87
ng/l
2.70
41
390
54
420
1.41
1.25
2.8
3.7
7.40
7.40
ph
—
9
74
84
704
1.37
1.25
4.0
3.5
0.00
0.01
estimate
—
10
151
47
357
1.43
1.24
1.3
1.3
0.87
1.36
u/ml
—
9
101
39
514
0.69
1.23
2.6
3.7
10.73
59.10
e6/l
2.72
29
352
7
31
2.31
1.11
1.1
1.4
—
—
—
0
0
35
462
0.70
1.10
2.1
2.4
—
—
—
0
0
27
188
1.52
1.10
1.3
1.3
440.00
415.45
titre
—
6
44
34
249
1.45
1.09
1.3
1.3
1.08
6.13
u/ml
—
10
91
50
394
1.38
1.07
3.4
3.2
—
—
—
0
0
17
107
1.65
1.04
1.5
1.4
—
—
—
0
0
153
1435
1.51
1.03
4.6
4.4
1.37
1.47
mmol/l
2.21
139
1328
33
435
0.70
1.02
2.3
3.2
11.80
188.35
e6/l
0.62
24
328
16
100
1.66
1.00
1.3
1.2
53.82
202.89
iu/ml
2.38
11
37
0
31
0.00
0.97
0.0
3.4
—
4.60
—
0
31
0
31
0.00
0.97
0.0
4.3
—
58.52
—
0
31
7
37
1.93
0.95
2.4
2.2
23.13
24.86
mmol/l
—
7
37
6
27
2.26
0.94
1.2
1.6
—
—
—
0
0
59
487
1.32
0.92
5.9
4.8
2.33
1.90
ug/l
0.42
52
433
11
63
1.80
0.92
3.1
2.4
—
—
—
0
0
11
63
1.80
0.92
1.9
2.8
—
—
—
0
0
6
111
0.52
0.86
1.0
1.4
—
—
—
0
0
14
89
1.62
0.84
1.7
10.3
—
—
—
0
0
34
264
1.36
0.80
1.2
1.2
16.33
26.94
iu/ml
0.70
12
85
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
81
709
1.26
0.79
5.7
4.8
0.00
0.00
estimate
—
9
139
82
719
1.26
0.79
4.0
3.5
0.00
0.00
estimate
—
8
126
22
159
1.44
0.77
3.1
12.5
1.91
1.12
mmol/l
0.31
13
132
9
53
1.74
0.77
1.1
1.1
—
—
—
0
0
7
117
0.58
0.71
6.4
10.8
—
—
—
0
0
5
28
1.81
0.66
1.2
1.3
—
—
—
0
0
13
187
0.67
0.65
1.5
1.3
—
—
—
0
0
5
30
1.69
0.62
1.6
1.9
—
—
—
0
0
0
21
0.00
0.60
0.0
2.2
—
—
—
0
0
0
22
0.00
0.59
0.0
4.3
—
—
—
0
0
12
172
0.68
0.59
1.9
8.8
104.83
103.99
mmol/l
0.52
12
172
8
53
1.53
0.59
1.3
1.4
—
—
—
0
0
50
579
0.81
0.59
2.1
2.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
0
23
0.00
0.58
0.0
4.0
—
—
—
0
0
146
1393
1.28
0.56
3.9
4.0
1.42
1.30
mmol/l
1.07
131
1279
14
99
1.45
0.56
1.0
1.2
—
37.13
—
0
6
75
671
1.21
0.56
4.9
6.0
—
—
—
0
0
82
741
1.20
0.54
4.1
5.6
0.21
0.19
e9/l
0.81
75
655
14
100
1.43
0.53
3.4
2.1
—
—
—
0
0
47
541
0.82
0.51
3.1
2.8
—
—
—
0
0
91
834
1.19
0.51
6.4
9.2
4.16
4.08
e9/l
0.13
84
724
55
482
1.21
0.50
2.5
3.3
2.34
2.36
mmol/l
0.44
47
424
12
85
1.44
0.48
1.1
1.2
—
—
—
0
0
7
50
1.42
0.45
1.3
1.5
24.23
20.68
iu/l
—
7
39
38
325
1.22
0.44
2.1
2.2
2.65
3.01
mg/l
0.69
32
278
24
290
0.80
0.41
1.4
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
8
60
1.35
0.41
1.8
1.7
—
—
—
0
0
11
148
0.73
0.40
1.5
1.8
—
—
—
0
0
42
367
1.19
0.39
3.0
4.6
—
—
—
0
0
31
362
0.83
0.39
3.9
6.8
—
—
—
0
0
13
98
1.35
0.38
2.1
2.6
3.68
6.38
e9/l
0.54
13
83
48
426
1.17
0.38
3.4
2.7
—
—
—
0
0
13
165
0.77
0.33
1.3
1.3
—
—
—
0
0
10
132
0.74
0.33
4.8
4.3
—
—
—
0
0
37
414
0.87
0.29
4.9
3.9
—
—
—
0
0
9
117
0.76
0.28
1.8
1.9
8.53
14.15
nmol/l
—
9
108
8
64
1.26
0.28
2.6
2.7
0.60
0.66
%
—
8
64
12
149
0.79
0.27
1.1
1.4
—
—
—
0
0
16
190
0.83
0.25
1.4
1.3
—
—
—
0
0
25
283
0.86
0.23
3.1
3.0
1.17
0.70
ug/l
0.74
13
182
5
39
1.29
0.23
3.0
2.3
8.82
8.17
kpa
—
5
39
7
94
0.73
0.23
6.1
8.1
25.14
25.15
mmol/l
—
7
94
5
40
1.26
0.22
3.0
1.9
2.88
5.85
iu/l
—
5
14
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
35.00
—
0
11
0
11
0.00
0.21
0.0
1.1
—
204.16
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
3.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
6
48
1.26
0.20
1.3
1.7
210.00
345.16
mu/l
—
6
43
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
6
51
1.18
0.19
2.7
4.8
—
—
—
0
0
33
302
1.11
0.17
1.3
1.8
0.96
1.46
mg/l
0.69
21
237
41
386
1.08
0.13
4.1
3.7
0.00
0.00
estimate
—
9
137
10
85
1.19
0.12
1.1
1.2
—
—
—
0
0
5
44
1.14
0.10
1.0
1.2
0.21
0.24
g/l
—
5
44
14
126
1.12
0.09
3.3
4.2
—
—
—
0
0
12
134
0.89
0.09
1.2
1.3
—
—
—
0
0
6
58
1.04
0.08
1.5
1.7
—
—
—
0
0
31
327
0.94
0.08
1.3
1.4
2.51
2.49
g/l
0.02
22
193
18
166
1.09
0.08
1.3
1.4
—
—
—
0
0
8
74
1.08
0.07
6.9
3.3
—
—
—
0
0
8
93
0.85
0.07
1.6
1.9
1.59
1.20
g/l
—
8
84
9
103
0.87
0.06
2.6
2.0
—
—
—
0
0
12
130
0.92
0.05
1.3
1.5
—
—
—
0
0
20
211
0.94
0.04
2.3
2.3
24.98
23.33
%
—
6
182
22
229
0.96
0.03
1.3
1.6
—
—
—
0
0
13
122
1.07
0.03
3.5
4.1
5.65
5.83
kpa
0.27
13
117
11
103
1.07
0.02
3.1
2.9
4.24
4.52
kpa
0.21
11
98
17
174
0.97
0.00
1.1
1.6
—
—
—
0
0
42
421
1.00
0.00
1.3
1.4
—
—
—
0
0
12
123
0.97
0.00
2.8
3.7
—
—
—
0
0
33
333
0.99
0.00
4.2
3.3
—
—
—
0
0
11
105
1.05
0.00
2.1
3.4
—
—
—
0
0
24
242
0.99
0.00
1.9
3.4
0.83
0.81
mmol/l
0.56
24
230
0
8
0.00
0.00
0.0
12.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
5
57
0.87
-0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
1.48
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
11.2
—
1198.11
—
0
9
0
9
0.00
-0.00
0.0
14.4
—
2260.33
—
0
9
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
12.71
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.4
1.3
—
—
—
0
0
5
59
0.84
-0.00
1.2
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
1870.71
—
0
7
5
59
0.84
-0.00
1.4
1.4
—
—
—
0
0
5
59
0.84
-0.00
3.8
9.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
6
66
0.91
-0.00
1.3
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
43.20
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
30.00
—
0
6
0
6
0.00
-0.00
0.0
34.7
—
95.17
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H8_MYRINGCHRON and mortality.

Females

Parameter HR [95% CI] p-value
H8_MYRINGCHRON 0.971 [0.69, 1.37] 0.867
Birth year 0.995 [0.99, 1.0] 0.274

During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 610 females with H8_MYRINGCHRON died.

Males

Parameter HR [95% CI] p-value
H8_MYRINGCHRON 0.866 [0.64, 1.18] 0.359
Birth year 0.987 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 607 males with H8_MYRINGCHRON died.

Mortality risk

Mortality risk for people of age

years, who have H8_MYRINGCHRON.

N-year risk Females Males
1 0.117% 0.183%
5 0.575% 0.998%
10 1.505% 2.504%
15 2.861% 4.861%
20 4.939% 8.169%

Relationships between endpoints

Index endpoint: H8_MYRINGCHRON – Chronic myringitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data